The Deadly Secrets Behind “Breakthrough” Alzheimer’s Drugs
Regulators approved controversial therapies amid excess deaths, questionable efficacy, and conflicts of interest.
Deeply reported, carefully crafted stories that explore the human toll of corporate greed and political corruption.
Regulators approved controversial therapies amid excess deaths, questionable efficacy, and conflicts of interest.
Chris Deluzio keeps winning a battleground district in the nation’s most pivotal swing state — could he point the way forward for his floundering party?
Los Angeles’ wildfires and an industry-tied insurance regulator may prove a tipping point for the country’s faltering financial safety net.
The promises of Klarna and other “buy now, pay later” companies are too good to be true.
Failure to block the insurance giant’s market consolidation, including by a judge with a potential conflict of interest, has led to worse care, higher prices, and a mounting human toll.
A radical magic contest reveals the secrets of manipulation in a post-truth world.
In the heart of the state that could decide the election, people are grappling with a crisis largely ignored by both Trump and Harris.
The industry aims to expand its reach this election season by promising revenue windfalls and downplaying evidence their services are a bad bet.
How Hurricane Milton and other climate chaos could trigger the next economic crisis.
In one of the world’s most valuable fisheries, regulators with conflicts of interest are letting corporations off the hook.